Potentiation of arsenic-induced cytotoxicity by sulfur amino acid deprivation (SAAD) through activation of ERK1/2, p38 kinase and JNK1: the distinct role of JNK1 in SAAD-potentiated mercury toxicity

被引:13
|
作者
Son, MH
Kang, KW
Lee, CH
Kim, SG
机构
[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
[2] Dong A Pharmaceut Res Labs, Kyonggi Do 449900, South Korea
[3] Hanyang Univ, Coll Med, Seoul 133791, South Korea
关键词
arsenic; mercury; heavy-metals; cytotoxicity; sulfur amino acid; MAP kinase; ERK; p38; kinase; JNK;
D O I
10.1016/S0378-4274(01)00314-9
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Sulfur amino acid deficiency occurs in certain pathophysiological situations (e.g. protein-calorie malnutrition). Previous studies revealed that sulfur amino acid deprivation (SAAD) activated MAP kinases and potentiated cadmium-induced cytotoxicity by activation of ERK1/2 in conjunction with p38 kinase or JNK. The present study was designed to determine susceptibility of cells to a variety of heavy metals in combination with SAAD. Viability was assessed in H4IIE cells treated with sodium arsenite. mercuric chloride, sodium selenite, lead acetate, chromium trioxide or manganese chloride. SAAD potentiated the cytotoxicity of H4IIE cells by arsenic or mercury (i.e. EC50, 19 and 5 muM in SAAD vs. 401 and 42 muM in control medium, respectively). TUNEL assays revealed that the potentiated arsenic or mercury toxicity involved apoptotic cell death. Lead or selenite moderately elicited cell death. which was not enhanced by SAAD. Chromium or manganese caused no significant cytotoxicity. Treatment of cells with U0126 [1,4-diamino-2,3-dicyano-1.4-bis(2-aminophenylthio)butadiene] an ERK1/2 inhibitor or SB203580 [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole] a p38 kinase inhibitor effectively prevented SAAD-potentiated arsenic toxicity. The potentiated arsenic toxicity was also inhibited in cells stably expressing a dominant negati\;e mutant of c-Jun N-terminal kinase 1 [JNK1(-)]. The inhibitors of exrracellular signal-regulated kinase 1/2 (ERK1/2) and p38 kinase failed to prevent mercury-induced toxicity enhanced by SAAD. JNK1(-) cells were minimally susceptible to mercury in SAAD medium. These results demonstrated that SAAD potentiated cytotoxicity induced by arsenic or mercury and that activation of ERK1/2, p38 kinase and JNK1 was responsible for the potentiated arsenic toxicity. whereas the mercury toxicity enhanced by SAAD was mediated with the activity of JNK1. (C) 2001 Elsevier Science ireland Ltd. All rights reserved.
引用
收藏
页码:45 / 55
页数:11
相关论文
共 39 条
  • [1] Potentiation of cadmium-induced cytotoxicity by sulfur amino acid deprivation through activation of extracellular signal-regulated kinase1/2 (ERK1/2) in conjunction with p38 kinase or c-jun N-terminal kinase (JNK) - Complete inhibition of the potentiated toxicity by U0126 an ERK1/2 and p38 kinase inhibitor
    Son, MH
    Kang, KW
    Lee, CH
    Kim, SG
    BIOCHEMICAL PHARMACOLOGY, 2001, 62 (10) : 1379 - 1390
  • [2] Erk1/2 activation promotes compensated cardiac hypertrophy in transgenic mice while JNK1/2 or p38 activation promotes cardiomyopathy
    Bueno, OF
    De Windt, LJ
    Tymitz, KM
    Witt, SA
    Kimball, TR
    Klevitsky, R
    Hewett, TE
    Peng, CF
    Kitsis, RN
    Jones, SP
    Lefer, DJ
    Molkentin, JD
    CIRCULATION, 2000, 102 (18) : 288 - 288
  • [3] Activation and role of MAP kinase-dependent pathways in retinal pigment epithelium cells: JNK1, P38 kinase, and cell death
    Hecquet, C
    Lefevre, G
    Valtink, M
    Engelmann, K
    Mascarelli, F
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (03) : 1320 - 1329
  • [4] Hispolon from Phellinus linteus possesses mediate caspases activation and induces human nasopharyngeal carcinomas cells apoptosis through ERK1/2, JNK1/2 and p38 MAPK pathway
    Hsieh, Ming-Ju
    Chien, Su-Yu
    Chou, Ying-Erh
    Cheng, Chih-Jung
    Chen, Judy
    Chen, Mu-Kuan
    PHYTOMEDICINE, 2014, 21 (12) : 1746 - 1752
  • [5] Sphinganine induces phosphorylation of ERK1/ERK2, JNK1/JNK2, and p38 mitogen activated protein kinases in HT-29 human colon cancer cells.
    Ahn, EH
    Schroeder, JJ
    FASEB JOURNAL, 2002, 16 (05): : A974 - A974
  • [6] ERK1/2, but not p38-MAP kinase and JNK1/2, play a role in the mechanism of EGF-mediated protection of tight junctions (TJS']JS) from acetaldehyde
    Samak, Geetha
    Rao, Radhakrishna
    GASTROENTEROLOGY, 2008, 134 (04) : A569 - A569
  • [7] Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment
    de Lemos, Luisa
    Junyent, Felix
    Verdaguer, Ester
    Folch, Jaume
    Romero, Rafael
    Pallas, Merce
    Ferrer, Isisdre
    Auladaell, Carme
    Camins, Antoni
    JOURNAL OF NEUROCHEMISTRY, 2010, 114 (05) : 1315 - 1322
  • [8] Glabridin Mediate Caspases Activation and Induces Apoptosis through JNK1/2 and p38 MAPK Pathway in Human Promyelocytic Leukemia Cells
    Huang, Hsin-Lien
    Hsieh, Ming-Ju
    Chien, Ming-Hsien
    Chen, Hui-Yu
    Yang, Shun-Fa
    Hsiao, Pei-Ching
    PLOS ONE, 2014, 9 (06):
  • [9] Cadmium-Induced Activation of JNK, but Not p38 or ERK1/2, in Mouse Embryonic Midbrain Cells in Micromass Culture
    Kapron, C. M.
    Liu, J.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2011, 91 (05) : 362 - 362
  • [10] Improved insulin sensitivity with calorie restriction does not require reduced JNK1/2, p38, or ERK1/2 phosphorylation in skeletal muscle of 9-month-old rats
    Sharma, Naveen
    Bhat, Abhijit D.
    Kassa, Anketse D.
    Xiao, Yuanyuan
    Arias, Edward B.
    Cartee, Gregory D.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2012, 302 (01) : R126 - R136